<DOC>
	<DOC>NCT02961361</DOC>
	<brief_summary>Dexmedetomidine is an α-2 adrenoreceptor agonist and has been extensively used through intravenous infusion，in order to improved the quality of block in regional anesthesia. In this prospective, randomized study, the authors focus on the effect of dexmedetomidine mixed with ropivacaine in coracoid approach brachial plexus block.</brief_summary>
	<brief_title>the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block</brief_title>
	<detailed_description />
	<mesh_term>Arm Injuries</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>1. American Society of Anesthesiologists (ASA) physical status I or II; 2. Aged 1860 years; 3. The elbow, forearm, wrist or hand surgery 1. History of allergy to local anesthetics; 2. Coagulation dysfunction, neuromuscular disease or local infection; 3. The operation time is longer than the local anesthetics effective time.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>dexmedetomidine</keyword>
	<keyword>coracoid</keyword>
	<keyword>brachial plexus block</keyword>
</DOC>